Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2250 of 3284 entries
View as:

Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00064714 Org: User:
Start: 07/31/03 End: 03/31/08 Due: 03/31/09

Assessment of Asthma Control Level in Primary Care Setting in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT03804632 Org: User:
Start: 10/23/17 End: 06/06/18 Due: 06/06/19

Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT01285180 Org: User:
Start: 08/31/10 End: 08/31/12 Due: 08/31/13

Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00497991 Org: User:
Start: 05/31/06 End: 04/30/10 Due: 04/30/11

Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00255281 Org: User:
Start: 09/30/05 End: 05/31/06 Due: 05/31/07

Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00494442 Org: User:
Start: 06/11/07 End: 07/20/17 Due: 07/20/18

A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

Phase: N/A Priority: Normal
NCT ID: NCT02962960 Org: User:
Start: 02/14/17 End: 12/17/18 Due: 12/17/19

Management of Advanced Non-Small Cell Lung Cancer (NSCLC) and Clinical Outcomes in Patients Who Received Gefitinib in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT01130961 Org: User:
Start: 10/31/09 End: 08/31/10 Due: 08/31/11

Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)

Phase: N/A Priority: Normal
NCT ID: NCT00163397 Org: User:
Start: 01/31/04 End: 07/31/05 Due: 07/31/06

ATAC - Bone Density Sub-Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00784940 Org: User:
Start: 06/30/98 End: 04/30/07 Due: 04/30/08

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00319306 Org: User:
Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU

Phase: N/A Priority: Normal
NCT ID: NCT00628862 Org: User:
Start: 12/31/07 End: 04/30/09 Due: 04/30/10

Study in Healthy Volunteers to Investigate the Effects of Rifampin on the Pharmacokinetics of NKTR-118

Phase: N/A Priority: Normal
NCT ID: NCT01533870 Org: User:
Start: 03/31/12 End: 05/31/12 Due: 05/31/13

Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00857623 Org: User:
Start: 02/28/09 End: 08/31/09 Due: 08/31/10

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00385593 Org: User:
Start: 09/30/06 End: 10/31/08 Due: 10/31/09

AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00912353 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)

Phase: N/A Priority: Normal
NCT ID: NCT00073177 Org: User:
Start: 11/30/03 End: - Due: -

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00687141 Org: User:
Start: 11/30/07 End: 06/30/08 Due: 06/30/09

Specific Clinical Experience Investigation for Long-term Use of Bydureon.

Phase: N/A Priority: Normal
NCT ID: NCT01940770 Org: User:
Start: 10/18/13 End: 11/29/19 Due: 11/29/20

A Cross-sectional Study of COPD and Symptom Variability in MEA Countries

Phase: N/A Priority: Normal
NCT ID: NCT03425760 Org: User:
Start: 12/07/15 End: 03/31/17 Due: 03/31/18

Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325

Phase: N/A Priority: Normal
NCT ID: NCT00681720 Org: User:
Start: 02/29/08 End: 07/31/08 Due: 07/31/09

Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00667992 Org: User:
Start: 04/30/08 End: 05/31/09 Due: 05/31/10

To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01148095 Org: User:
Start: 06/30/10 End: 07/31/10 Due: 07/31/11

A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib

Phase: N/A Priority: Normal
NCT ID: NCT03239340 Org: User:
Start: 05/30/18 End: 09/19/23 Due: 09/19/24

The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

Phase: N/A Priority: Normal
NCT ID: NCT00524251 Org: User:
Start: 06/30/04 End: 03/31/08 Due: 03/31/09